Physostigmine in Alzheimer's disease.
D000328:Adult; D000544:Alzheimer Disease / Q000503:physiopathology*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000503:physiopathology*; D004341:Drug Evaluation; D006801:Humans; D007279:Injections, Subcutaneous; D007361:Intelligence Tests; D008297:Male; D008568:Memory / Q000187:drug effects; D008569:Memory Disorders / Q000188:drug therapy*; D009483:Neuropsychological Tests; D010830:Physostigmine / Q000008:administration & dosage*; D010919:Placebos; D012107:Research Design
D010919:Placebos; D010830:Physostigmine